| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $255K | -35.9% |
| Cost of Revenue | $290K | -25.2% |
| Gross Profit | -$35K | -445.6% |
| R&D Expense | $920K | -33.4% |
| SG&A Expense | $2.1M | -1.9% |
| Operating Income | -$4.9M | +21.1% |
| Income Tax | $0 | — |
| Net Income | -$4.8M | -49.6% |
| EPS (Basic) | -$7.07 | -1372.9% |
| EPS (Diluted) | -$7.07 | -1372.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $7K | +27.6% |
| Inventory | $100K | -20.8% |
| Current Assets | $8.6M | +124.8% |
| Total Assets | $8.9M | +117.8% |
| Current Liabilities | $366K | -58.2% |
| Total Liabilities | $366K | -58.6% |
| Stockholders' Equity | $2.6M | -19.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -9.6% |
| Capital Expenditures | $28K | +50.4% |
| Investing Cash Flow | -$186K | -102.6% |
| Financing Cash Flow | $9.6M | +1266.4% |
| Free Cash Flow | -$5.1M | -9.7% |